Academics still haven’t cracked the molecular code to understand what, on a basic science level, causes mental illness like schizophrenia. This is the core reason why investors shy from investing in this widespread condition, a panel of venture capitalists said at this week’s World Medical Innovation Forum in Boston. It’s not because the target market, … Continue reading Why aren’t venture capitalists investing in mental illness?